News
09-04-2015, 08:35 AM
Population screening for BRCA gene mutations would prevent so few breast and ovarian cancer cases that its cost would not be worthwhile, say authors of a leading opinion article.
More... (http://www.medicalnewstoday.com/articles/298986.php)
More... (http://www.medicalnewstoday.com/articles/298986.php)